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The M  protein  is the cell-surface antigen of group A  streptococci responsible for 
resistance  to  phagocytosis  by  human  polymorphonuclear  leukocytes  (1,  2).  The 
antiphagocytic character of the M  protein has long been recognized as an important 
virulence factor in this organism. Although  the molecular basis of its activity is not 
entirely understood,  recent  reports suggest that M  protein retards the activation of 
the alternate complement pathway and subsequent opsonization of the bacterial cell 
(3, 4). There are more than 85 different serotypes of group A streptococci recognizable 
with  antisera  specific  for  the  M  protein;  and  antibody  to  this  protein  is  in  part 
responsible  for  immunity  to  streptococcal  infection.  The  genetic  relationship  of 
different  strains  and  the  genetic events responsible  for the  heterogeneity in  the  M 
antigen have not been studied. 
The phenotypic variability of the M  protein has been documented since Todd first 
isolated glossy morphological variants (5), and he and Lancefield demonstrated that 
they were M-  (lacking the M + phenotype) and avirulent for mice (6).  (Our criteria 
for the M + state is that  the streptococcal culture resists phagocytosis and produces 
acid-extractable M  protein.) Others have noted similar changes in M  protein content 
during convalescence from streptococcal infection (7), and in the throats of healthy 
carriers  (8).  Previous  work  in  our  laboratory  suggested  a  genetic  basis  for  this 
instability and we proposed that extrachromosomal DNA could be responsible for the 
M + phenotype (9). 
The literature is replete with examples of pathogenic bacteria that require bacte- 
riophages for the maximum expression of their virulence (10), and the high incidence 
of lysogeny in  group A  streptococci is equally well documented  (11).  With  this  in 
mind, we began an investigation into the role of prophage in the control of M  protein 
synthesis,  limiting  our  initial  studies  to  a  few  matched  pairs  (M  +  and  M-)  of 
laboratory  strains.  In  this  report,  evidence  is  presented  that  bacteriophages  are 
involved in  the  conversion of certain  M-  streptococci to an  M +  state,  resistant  to 
phagocytosis; and the implication of this information to genetic variation in group A 
streptococci is discussed. 
Materials and Methods 
Bacterial Strains.  Seven  strains of group A streptococci were used in these studies.  Strain 
K56 (T-12, M-12) was originally described and obtained from E. Kjems, the Streptococcal and 
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Media Departments, Statens Seruminstitut, Copenhagen, Denmark (12) and is herein referred 
to as strain CS24. Strain CS44, a phage A25-resistant mutant isolated from strain CS24, and 
strain CS64,  a  spontaneous, glossy M- variant of strain CS44, were originally described by 
Cleary and Johnson  (13).  Strain CS110 (T-12, M-76) also originated in the Kjems laboratory 
(Personal communication.) where it was referred to as strain 5641.  Strain CS112 was isolated 
as a small colony variant of strain CSI10 and purified by numerous blood agar plate (BAP) 1 
passages; the M- character of this strain was verified by its failure to grow in human blood 
(lack of antiphagocytic determinants) and by its lack of extractable M  antigen in unconcen- 
trated acid extracts. A spontaneous streptomycin-resistant (str  n  200 lag/ml) mutant of strain 
CS112 was isolated for use in these studies. Strains R72/943  (T-12, M-76), an M-76 prototype 
strain, and C98/105/2 (T-24, M-24), an M-24 prototype strain, were kindly supplied by Doctors 
W. R. Maxted and L. W. Wannamaker, respectively. The group A streptococci used in this 
study were classified by T  agglutination (14) and the M  type was determined by the capillary 
precipitation and immunodiffusion (15). 
For typing and  phagocytosis studies, bacteria were  grown  in  Todd-Hewitt broth  (Difco 
Laboratories, Detroit, Mich.) supplemented with 1% yeast extract (Difco Laboratories), whereas 
streptococci used for phage propagation were grown in No.  1 broth, as previously described 
(16). 
Bacteriophages.  Temperate  phages were isolated and  single plaques  purified by common 
techniques. Plaque-forming units (PFU) were assayed in soft agar overlays of strain CS112 or 
strain CS24. Bottom agar (273) consisted of 4% proteose peptose 3, 0.2% yeast extract, 0.03 M 
trizma base, 0.01  M  glycerolphosphate, 1.5% agar, 0.2%  glucose, 0.03%  CaCI2, and 68/~g/ml 
hyaluronidase (Sigma Chemical Co., St. Louis, Mo.) (S. Skjold. Personal communication.). Z6 
top agar has been described (13). 
High titer phage lysates used in the preparation of antisera were prepared as follows: a 600- 
ml  log-phase culture of CS 112  was grown in  modified No.  1 broth, devoid of glucose and 
supplemented with 68 pg/ml hyaluronidase and 0.5% trypsin (Difco Laboratories, 1:250); after 
resuspension  in  fresh  modified  No.  1  broth  without  trypsin,  the  cells were  infected  at  a 
multiplicity of 0.01  and  incubated  at  37°C  for 6  h.  Phage particles were concentrated by 
centrifugation and were resuspended in suspension medium consisting of 10 mM trizma base, 
70 mM NaCI, 0.005%  gelatin, and 0.1 mM MgSO4 at pH 7.4. 
Production of Anti-Phage Sera.  Rabbits were subcutaneously inoculated with 2 ×  10 L° PFU in 
a  1:1 mixture of phages and Freund's incomplete adjuvant (Difco Laboratories). 
Phage  Curing.  Log-phase cultures of lysogens were spread on  273  plates with undiluted 
phage-specific antiserum and the plate was irradiated with a dose of ultraviolet light yielding 
10  -5 colony-forming units (CFU) survival. Survivors were screened for the presence of the phage 
in question. Putative cured clones were purified by BAP passage, assayed for susceptibility to 
phages SP24 and SP44, and finally shown not to produce phage on 0.1 /~g/ml mitomycin C 
(Sigma Chemical Co.) induction. 
Resistance  to Phagocytosis.  Cultures were tested for resistance to phagocytosis by their ability 
to grow in human blood, employing methods previously described (9,  17). M  antigen-specific 
opsonin was assayed by a modification of Lancefield's procedure (14) as described by Cleary et 
al. (18). 
Production of Anti-M Sera.  Antisera used in these studies were prepared by inoculation of 
rabbits with whole cell vaccines and absorbed by standard procedures (19).  RS800 antiserum 
has been previously described (18);  RS4 antiserum was made using the constructed lysogen, 
strain 272, as a vaccine (see Results). 
Agar Diffusion and Immunoelectrophoretic Studies.  Double-diffusion studies were done on large 
glass plates (10.0 ×  8.0 cm) or microscope slides overlayed with double-diffusion agarose, made 
as previously described (18).  Precipitin arcs were photographed directly, after incubation at 
25°C. 
Immunoelectrophoresis (IEP)  studies were carried out on microscope slides as previously 
l Abbreviations used in this paper: BAP, blood agar plates; CFU, colony-forming unit; IEP, immunoelectro- 
phoresis;  P1,  preeipitinogen  1;  P2,  precipitinogen  2;  PFU,  plaque-forming  unit;  SRID, single radial 
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described (20),  with the exception that  slides were incubated at  25°C  after the addition of 
antisera. 
Single radial immunodiffusion (SRID) was performed on microscope slides according to the 
procedure of Mancini et al. (21). These slides were also incubated at 25°C. 
All immunological assays were done on acid extracts that had been concentrated by ethanol 
precipitation according to the method of Lancefield (22);  and these concentrates were assayed 
for total protein by the Lowry method  (23),  so that equivalent amounts of acid extractable 
protein were always added to immunodiffusion or IEP wells. 
T~ypsin Digestion.  Concentrated acid extracts were mixed with an equal volume of  phosphate 
buffer (0.06 M phosphate, pH 7.8) containing 5.0% trypsin (Difco Laboratories, 1:250) and this 
mixture was incubated at 37°C for 30 min. Trypsinization was stopped by the addition of 20 
mg/ml trypsin inhibitor (Sigma Chemical Co.) and another 30-min incubation at 37°C. 
Results 
Strain CS112,  an M-, str  R derivative of strain CS110  (T-12, M-76), was chosen as 
the recipient because it proved sensitive to a wide range of the bacteriophages initially 
examined (unpublished results). Strain CS24 and its derivatives were decided upon as 
phage  donor  strains  because  they  have  different  type-specific and  antiphagocytic 
determinants  (M-12)  than  those  of the  parent  of the  recipient  strain  (M-76),  and 
because the M + phenotype of strain CS24 was known to be unstable (13). 
Bacteriophage  Isolation, Comparison,  and Nomenclature.  First, bacteriophages present in 
the phage donor and recipient strains were compared. They were isolated from the 
supernate of overnight cultures, and purified by three successive single-plaque isola- 
tions. Phages were named according to their origin. 
Phages  SP24,  SP44,  and  SP64,  originating from  strain  CS24  and  its  derivatives 
CS44  and  CS64,  formed  plaques  on  strain  CSl12;  and,  these  phages  have  been 
tentatively identified as the same by virtue of their common host range and reciprocal 
immunity to superinfection  (Table I). This conclusion is further supported by their 
identical phage neutralization kinetics (using antisera directed against phage SP44) 
and  by  preliminary  restriction  endonuclease  mapping  of  their  respective  DNAs 
TABLE  I 
Sensitivity of Wild-type and Laborato~7-constructed Lysogens to Bacteriophage 
Carried by Group A Streptococci 
Indicator lawns* 
Lysis by induced cultures of strains~: 
CS24  CS44  CS64  CS112 
* Strains CS24, CS44, CS64, and CS112 are wild-type strains; whereas strains 
CS112  (SP24), CSll2  (SP44), and CSll2  (SP64) are lysogens of CSI12 
constructed from phage that were plaque purified from the wild-type strains. 
Isolates were considered lysogenic if they produced phages that plaqued on 
the uninfected indicator strain  CS112, but were resistant to superinfection 
by that infecting phage. 
:~ (+), the formation of plaques; (-), no plaques observed. 
CS24  -  -  -  + 
CS44  -  -  -  + 
CS64  -  -  -  + 
CS112  +  +  +  - 
CS112 (SP24)  .... 
CS112 (SP44)  .... 
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(unpublished  data). Phage SP 112 produced plaques on strain CS24 and its derivatives, 
and did not share immunity to superinfection by those phages (Table I); thus, phage 
SP112  represented an unrelated phage strain harbored by the  M-  indicator strain 
CSl12. 
Construction of Lysogens.  To test  the possibility that  these phages could control or 
regulate M-protein expression, we constructed lysogens of the  M-  strain CS1 12  by 
plating phage SP24 or SP44 on soft agar overlays of that strain. Lysogenic cells were 
picked from the turbid area within individual plaques or zones of lysis. Colonies were 
considered lysogenic if they produced a  phage that grew on the uninfected indicator 
strain CS112, and were also resistant to superinfection by that infecting phage (Table 
I). Because all of the phage donor strains were streptomycin sensitive, an additional 
control was to verify that the CS112-constructed lysogens were str  R. 
Our initial approach was to isolate CS112  lysogens--independent of the M  phe- 
notype--and then  ask  whether  the  M  phenotype  of strain  CSl12  had  changed. 
Randomly picked colonies, verified to be lysogens, were then tested for their potential 
to resist phagocytosis. In two separate experiments, 2 out of 7 and 3 out of 10 lysogens 
were partially M +,  as evidenced by their survival in blood; but, they proved to be 
very unstable, and quickly reverted to the M- state upon additional broth or plate 
passage. The precise frequency of conversion to the M + state could not be quantitated, 
but one point was clear: all lysogens were not M +. 
Selection  of M ÷ Convertants  by Rotation in Human Blood.  In an effort to stabilize the 
M + phenotype, M + lysogens were selected by repeated incubation in human blood 
(9). Lysogens enriched in this manner became more stably resistant to phagocytosis, 
whereas similar section and passaging of strain CS112 in blood invariably resulted in 
its eradication; any cells surviving the first exposure to blood were readily phagocy- 
tized upon reintroduction to fresh blood (Table II). 
As further evidence that the M--recipient strain CS112 did not revert to the M + 
TABLE II 
Enrichment  for M + Cells by Incubation m Fresh Human Blood 
Fraction survivors* 
Presence of  Strain no.  prophage  Day l incubation  Day 2 incubation  Day 3 incubation 
1  2  3  4  5  6 
CS112  --~  2.5  0.05  1.28  0.01  ND§  ND 
272  SP24  2.65  0.80  3.56  5.39  83  1280 
275  SP24  2,1  1.28  4.811  91.3  4.011  9O 
157  SP44  10,2  142  45.2  517  ND  ND 
* Log-phase cultures were diluted and added to freshly drawn human blood. The number of CFU added 
to blood was determined by viable counts, and this number was used as 1 (100% survival). The fraction 
of survivors  equals the number of viable CFU at the indicated times divided by the number of CFU at 
time zero. After 3 h, survivors  were added to fresh blood (1:3 dilution) and reineubated for an additional 
3 h  (unless otherwise indicated). After day  1, survivors were grown overnight in No.  1 broth,  then 
transferred to Todd-Hewitt broth and yeast extract and grown to log phase before dilution into freshly 
drawn human blood. 
:~ Strain CS112 harbors an endogenous prophage SP112, only; whereas strains 272 and 275 are independ- 
ently isolated CS112 lysogens-carrying  phage SP24. Strain 157 is a CS112 lysogen-carrying  phage SP44. 
§ ND, not done. 
{[ Serial transfer was made after 1 h; thus, the fraction of survivors was measured at 1 and 4 h, rather than 
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state, independent of the bacteriophage, we did the following experiment: CS 112 was 
serially transferred eight consecutive times into fresh human blood over a 24-h period. 
Despite an initial population of:> 107 CFU, no M + survivors (resistant to phagocytosis) 
could be isolated from this nonlysogenic-recipient strain (data not shown). 
Three independently isolated  M+-enriched lysogens, strains  157  (CSl12  [SP44]) 
and 272 and 275 (CS112 [SP24]) were studied in more detail. If phage were required 
for M-antigen expression, then their loss  should return the culture to the M- state. 
Cured derivative strains  157c and 272c were isolated from lysogenic strains  157 and 
272,  respectively, after UV induction and  growth in the presence of phage-specific 
antisera. As expected, these cured strains were sensitive to phage SP24 and SP44 and 
could not be induced to produce those phages by either mitomycin C  or UV when 
lysates were assayed on the indicator strain CS 112. When present, phages SP24 and 
SP44 are easily induced by mitomycin C.  Strains  157c and 272c were purified by 
BAP passage,  and  tested for susceptibility to phagocytosis. A  typical experiment is 
shown in Fig.  1. Phage donor strains CS24 and CS44 and strain CS112 lysogens 157, 
272, and 275 mutliplied in blood, clearly indicating their resistance to phagocytosis. 
The  recipient  strain  CSl12  and  cured  derivatives  157c  and  272c  were  readily 
phagocytized. 
Specificity  of Antiphagocytic  and  Precipitating  Determinants  of Converted M +  Lysogens. 
Because  these  lysogens were clearly resistant  to  phagocytosis, it  was  important  to 
determine whether they possessed  M-protein  determinants  antigenically similar  to 
those produced by the M-12 phage donor strain or to those produced by the parent 
of the M--recipient strain. The specificity of antiphagocytic determinants was evalu- 
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Flo.  1.  Resistance to phagocytosis of phage donor and phage-recipient strains, constructed lyso- 
gens, and strains cured of their prophage. Growth in rotated blood of phage donor strains CS24 and 
CS44 and phage-recipient strain CS112  are compared to growth by CS112  lysogens, strains 157, 
272, and  275,  and  phage-cured derivative strains  157c  and  272c.  Growth  in  human blood  was 
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ated by susceptibility to phagocytosis of cells preopsonized with type-specific opsonic 
antisera, because opsonic antibodies specifically prepare M + streptococci for phago- 
cytosis. The M-76 antisera used in  these experiments was RSS00,  made against  an 
unrelated M-76 strain as previously described (18); whereas the M-12-specific antisera 
was prepared by using heat-killed cells of strain CS44 as a  vaccine. 
Log-phase cells  were  preopsonized  by  a  30-rain  incubation  with  preimmune  or 
type-specific  antisera,  then  added  to  freshly  drawn  human  blood  and  incubated 
(rotating)  for an additional  30 min. A comparison of viable counts taken before and 
after rotation in blood indicated a  particular culture's susceptibility or resistance to 
phagocytosis. The data from these experiments demonstrated that preopsonization of 
strain  CSll0  and  strain  CSl12  lysogens with  M-76  antisera  resulted  in  the  rapid 
phagoeytosis of those M + strains (Fig. 2). When these same cultures were preopsonized 
with preimmune or M-12 antisera, they remained resistant  to phagocytosis. Similar 
preopsonization of phage donor cells, strain CS24, with M-12 antiserum resulted in 
their  rapid  phagocytosis when  incubated  with  freshly drawn  human  blood.  Strain 
CS24,  however, remained resistant  to phagocytosis despite preopsonization with M- 
76 or preimmune sera. An unrelated strain, C98/105/2  (M-24), was not phagocytized 
after preopsonization with either M-12 or M-76 antisera (data not shown). Therefore, 
we concluded that M + CS112 lysogens possessed the antiphagocytic determinants of 
the parental M-76 strain CS110  rather than those of the M-12 phage donor strains 
CS24 and CS44. 
Precipitating determinants were compared by double-diffusion analysis employing 
concentrated acid extracts, prepared according to the method of Lancefield (22), and 
rabbit  serum  directed  against  one  M ÷  lysogen,  strain  272.  Because  this  antiserum 
(referred  to  as  RS4)  was  able  to  precipitate  acid  extracts  of the  unrelated  M-76 
prototype strain R72/943  (see below), and opsonize all M-76 strains against which it 
was tested  (unpublished  data), we believed it contained  antibodies directed against 
M-76 determinants and will refer to it as M-76 antiserum. 
When  the  center well contained  RS4,  a  continuous  precipitin  line  was observed 
between  wells  containing  concentrated  acid  extracts  of strain  R72/943  (an  M-76 
prototype strain), CS110, and the M+-converted lysogens (strains  157,  272, and 275) 
(Fig. 3). The common antigenic determinants shared by these strains will be referred 
ANTISERA 
I  ++,,!+ 
M-'P~ 
CSIfO  157  27~'  CS24 
Fxo.  2.  Opsonization of M + lysogens by hyperimmune rabbit antisera. M + parental strains CS24 
and CS110, and M + lysogens 157 and 272 wen preopsonized by M-12, M-76 or normal (NS) rabbit 
anti~ra as described in Methods. The fraction of survivors equals the viable CFU after a 30-rain 
incubation in rotated human blood divided by the CFU initially added to the blood. J.  G.  SPANIER  AND  P.  P.  CLEARY  1399 
FIG. 3.  Immunodiffusion analysis of M  + extracts. Center wells contain RS4 antiserum. Peripheral 
wells contain acid extracts, concentrated fourfold by ethanol precipitation, as described by Lance- 
field  (22). The extract  wells are  labeled with  the  appropriate  strain  designations. Equivalent 
amounts of acid extractable protein were added to each well; protein concentration was determined 
by the Lowry method (23). Incubation was at 25°C for 18 h. 
to  as  precipitinogen  one  (P1).  P1  was  not  detectable  in  concentrated  acid  extracts 
made  from strains  CS112  and  272c.  However,  a  second  more peripheral  precipitin 
line was seen in extracts made from these two strains;  and, this line (P2) appeared  to 
cross  the  inner  common  P1  line,  which  suggested  a  lack  of serological  relatedness 
between  precipitinogens  P2  and  P1.  Similarly  prepared  extracts  of strain  CS24 did 
not result in precipitin arcs;  therefore,  the RS4 vaccine strain  272, an M + lysogen of 
strain CS 112, did not share antigenic determinants with the M-12 phage donor, strain 
CS24. 
Because extracts  of strains  CS112 and  272c contained a  preponderance  of P2, we 
could not rule out the possibility that this precipitinogen was obscuring the presence 
of P1  in  those extracts.  To test  this  notion, we further analyzed the acid extracts of 
strains  CSl12  and  272  by  IEP  on  agar  slides.  This  approach  also  revealed  two 
precipitinogens  (Fig. 4). The first barely moved in the electric field, migrating slowly 
towards the anode--a position characteristic  of M  proteins  (18, 24). This precipitin- 
ogen  was  present  in  both  272  and  CSl12  preparations,  although  it  was  barely 
detectable  in  the  latter.  The  second precipitinogen  revealed  by IEP was positively 
charged,  migrating well  toward  the cathode.  This  antigen  was also present  in  both 
extracts, but was more abundant  in the CS112 preparation  (Fig. 4). 
To  further  distinguish  these  two  precipitinogens  and  because  the  M  protein  is 
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Fta.  4.  Immunoelectrophoretic  analysis of M  + extracts.  The  peripheral wells contain  fourfold 
ethanol concentrates  of acid extracts, prepared as in Fig. 3. The numbers  indicate the bacterial 
strains examined.  Equivalent  amounts of extractable protein (23), were added to each well. After 
current was applied (9 MA/slide) for I h, RS4 (M-76) antisera was added to the long center trough. 
Slides were incubated 24 h at 250C. Negative and positive indicate the voltage polarity. The upper 
slide represents untreated concentrated  acid extracts, whereas the lower slide shows extracts after 
trypsin treatment. 
were digested with trypsin. Trypsin digestion destroyed P1  (data not shown)  and the 
less mobile antigen observed by IEP (Fig. 4). In contrast P2, presumed to correspond 
to the very mobile, positively charged precipitinogen was resistant to trypsin (Fig. 4). 
Therefore, we conclude that P1  represents M  antigen and that  the M-  strain CS112 
may possess M  antigen  (but in minute amounts). 
To further substantiate the finding that the M-  strain CS 112 possessed some acid- 
extractable  M  antigen,  M-12  and  M-76  antisera  were  absorbed  with  a  heat-killed 
preparation  of  strain  CSl12.  Absorption  of  RS4  (M-76)  antiserum  removed  all 
precipitating antibodies  from  that  antiserum  (Fig.  5).  Similar absorption  of M-12 
antiserum did not remove M-12 precipitating antibodies; therefore, absorption of M- 
76 antibody from RS4 antiserum by CS112 ceils was specific, and not caused by some 
nonspecific interaction such as Fc receptors on the surface of CS112  cells. Thus,  the J.  G.  SPANIER  AND  P.  P.  CLEARY  1401 
FIG.  ,.5.  lmmunodittusion analysis of absorbed hyperimmune antisera. Heat-killed cells of CS 112 
were prepared according to the method of Moody et al.  (19), and used to absorb M-12 and M-76 
(RS4)  antisera as described in the Methods:  UNABS indicates wells containing unabsorbed sera; 
ABS indicates wells containing absorbed sera. M-12 and M-76 indicate wells containing M-12 and 
M-76 antisera; CS24 and 272 designate the wells that contain concentrated acid extracts of strains 
CS24 and 272. Incubation was at 25°C for 24 h. 
absorption  experiments supported  the contention that  CS112  cells retain  some M 
antigen, even though they are sensitive to phagocytosis. 
A quantitative comparison of extractable P1 from strains CS112 and 272 was made 
by SRID  (21).  Antiserum  RS4 was  incorporated into immunodiffusion agar while 
equal amounts of acid-extractable protein from strains CS 112 and 272 were added to 
the wells and allowed to diffuse out radially. After a  72-h incubation, a  linear (dose- 
dependent)  relationship  between  the  amount  of added  antigen  and  the  zone  of 
precipitate in the agar slides was observed (Fig. 6). In the undiluted 272 well, there 
were two distinct circular precipitates indicating two distinct Ab-Ag systems. Because 
the outer zone disappeared after trypsinization (data not shown), we concluded that 
this corresponded to M  antigen  (PI)  and  that  the inner band  corresponded to  P2 
(Fig.  3).  The  CSl12  wells  similarly  exhibited  two  distinct  zones  of precipitates; 
however, the outer, more concentrated precipitate was resistant to trypsin (data not 
shown), indicating that the tiny band could be M  protein. Assuming that the trypsin- 
sensitive zone corresponded to the M  antigen or P1  (Fig.  3), these assays indicated 
that  the  M +  lysogen  272  possessed  ~35  times  more  M  antigen  than  the  phage- 
recipient strain CS112. 
Discussion 
From the time of Pasteur, students of bacterial pathogenesis have recognized the 
genetic instability of virulence factors required for successful infection. Likewise, the 1402  PHAGE  CONVERSION OF  M  PROTEIN IN GROUP A STREPTOCOCCI 
FIG. 6.  Quantitation  of M antigen from strains CS112 and 272 by SRID. Immunodiffusion agar 
contains KS4 antisera (in a final dilution of 1:8). Wells contain twofold dilutions of concentrated 
acid extracts of strains CS 112 and 272. Equivalent amounts of acid extractable protein were added 
to each dilution. Slides were incubated at 25°C for 72 h. 
genetic  instability  of the  M +  phenotype  of  group  A  streptococci  has  been  long 
recognized (5, 6).  Investigations in our laboratory have attempted  to understand  the 
genetic basis of variation in M-protein synthesis. Initial studies showed that some M- 
variants, if single colonies were carefully purified by many passages on agar plates, do 
not detectably revert to the M + phenotype; and that curing agents, such as rifampicin, 
increase the frequency of M- colonies in M + cultures (9). These observations prompted 
us  to  suggest  that  extrachromosomal  DNA  is  involved  in  the  M +  phenotype.  The 
series of experiments  reported  here support  this possibility,  and  implicate  temperate 
bacteriophages as a  controlling element in M-protein synthesis. 
Based on the experiments  described here, we conclude that  there are at  least  two 
genes involved in the synthesis of the antiphagocytic M-protein molecule: one, mprA, 
contributed  by a  prophage;  a  second,  the structural  gene mprS, contributed  by the 
bacterium.  Our  evidence  for phage  involvement  in  the  expression  of M  protein  is 
that:  (a)  M-  cultures  can  be  converted  to the  M +  state  (resistant  to  phagocytosis) 
upon  lysogenization  with  appropriate  bacteriophages;  (b)  without  those  bacterio- 
phages the M--recipient culture could not be detected to revert to the M + state, even 
under  our  most stringent  selective  conditions;  and  (c)  stable  M +  lysogens cured  of 
their  bacteriophages  returned  to  the  M-  state.  This  phage  mediated  conversion  is 
unlikely to be the result of transduction  because our converting phages were always 
cycled through the M- recipient,  strain CS112, a  number of times before conversion 
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specificity of the parental M-76 strain and not that of the M-12 phage donor strains; 
and the M ÷ phenotype required that the prophage be retained by the streptococcal 
cells. 
The structural gene, mprS, which determines the antigenic specificity of M  protein 
does not  reside on the prophage genome, but  is either located on the streptococcal 
chromosome or on a yet unidentified extrachromosomal element. This conclusion is 
supported by the fact that M ÷ lysogens, tested thus far, produce M  antigen which is 
identical to that  produced by the M + parent of the recipient strain, strain  CSll0. 
Antigenic determinants were compared by double-immunodiffusion analysis employ- 
ing concentrated acid extracts and rabbit serum directed against one lysogen, strain 
272. This serum, RS4, formed precipitates with all M-76 extracts and opsonized all 
M-76 strains tested, including the M-76 prototype strain. From immunodiffusion and 
immunoelectrophoresis analyses  we  were  able  to  conclude that  the  parent,  strain 
CSI10,  the  prototype M-76  strain,  and  lysogens  157,  272,  and  275,  all  have  the 
antigen designated P 1, that was presumed to be the M  antigen based on its trypsin 
sensitivity and mobility in an electric field (18,  24).  Furthermore, these strains also 
produced  a  trypsin-resistant  antigen,  P2,  that  migrated  in  an  electric field unlike 
other known streptococcal products. Extracts of the M- recipient, strain CS112 and 
the cured strain 272c retained the trypsin-resistant antigen, P2, but had very reduced 
quantities of a trypsin-sensitive antigen, possibly corresponding to P 1 and detectable 
only in concentrated extracts. Quantitation of these antigens by SRID demonstrated 
that extracts of the M + lysogens had ~35 times more P1  antigen than extracts from 
the phage recipient, strain CS 112, even though both extracts contained equal amounts 
of total protein. Absorption studies also supported the contention that strain CS112 
retains a  small amount of M  antigen.  These cells, when incubated with antiserum 
RS4, removed all precipitating antibody. Because P 1 was not detectable in unconcen- 
trated acid extracts of strain CS112, and because it was barely detectable in concen- 
trated extracts, we cannot be certain that this antigen is qualitatively the same as that 
isolated from other M-76 strains and M ÷ CS112 lysogens. CS112 cells obviously retain 
the genetic information for M-76 antigen; therefore, it is not unreasonable to expect 
the synthesis of small amounts of this antigen in extracts of this strain. This result also 
supports the notion that the structural gene mprS is intact in at least some cells in the 
culture. Of course definitive proof that strain CS112 possesses extractable M  antigen 
remains dependent upon the purification of the putative M antigen and subsequently 
showing its biochemical and immunochemical identity to P 1 extracted from M ÷ cells. 
At this time, we are unable to propose a precise function for bacteriophage in the 
expression of the M + phenotype nor can we say with certainty that the bacteriophage 
genes are involved in the transition between the M ÷ and M- states. The phage could 
participate directly in the biosynthesis of antiphagocytic M  protein or interfere with 
its destruction by proteolytic enzymes. A  precedent for the former is the temperate 
phages  of Salmonella  anatum  that  encode  glucosyl  transferases  and  transacetylases 
required for the synthesis of specific somatic antigens (25).  Phage SP24, for example, 
could encode a cross-linking enzyme which would covalently link type-specific peptide 
monomers to form an antiphagocytic molecule. Fischetti et al.  (26)  have suggested 
that such an enzyme might exist in M + streptococci. Alternatively the phage could 
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various  mechanisms  of transcriptional  control,  however,  are  too  numerous  to  be 
discussed here. 
Still  unexplained,  however, is  the observation that  many CS112  (SP24)  lysogens 
retain their original M- state. A  trivial explanation  for this is that the heterologous 
(M-12 and M-76) nature of the phage/host system used in these studies precludes the 
efficient cooperation of the mrpA and mprS genes in M-protein synthesis. Another 
possibility is that the "on-off" states of the M + phenotype reflect alternate states of 
the prophage genome;  therefore despite plaque purification,  the phage SP24  lysate 
could consist of two subpopulations, only one of which is able to activate M-protein 
synthesis. 
The  genetic  mechanism  by which  wild-type cells  become M-  remains  an  open 
question. Random mutation in either prophage or chromosomal genes could produce 
the M-  state;  however, we suggest  that a  specific genetic event is responsible. This 
could  involve  site  specific  inversion,  deletion,  or  insertion  of a  controlling  DNA 
segment in either chromosomal or prophage DNA.  Site-specific inversion of a  regu- 
latory sequence has been shown to be responsible for phase variation in Salmonella 
(27)  and in bacteriophage Mu (28); moreover, it has been recently shown that phage 
gene products can promote this inversion (29).  The site-specific insertion of bacterio- 
phage Mu or IS2 adjacent to or into a gene can alter that gene's expression (28); thus 
a specific interaction between phage SP24 and bacterial DNA could be required for 
the M + phenotype. These possibilities are now under investigation in our laboratory. 
Summary 
At  least  two  genes  have  been  shown  to  be  required  for  the  expression  of the 
antiphagocytic  M  protein  molecule  in  group  A  streptococci.  Evidence  for  phage 
involvement in the expression of M  protein is that:  (a) M- cultures of bacteria can be 
converted  to  the  M +  state  (resistant  to  phagocytosis)  upon  lysogenization  with 
appropriate bacteriophages; (b) without those bacteriophages the M- recipient culture 
could not be detected to revert to the M + state, even under our most stringent selective 
conditions;  and  (c) stable M + lysogens cured of their bacteriophages returned to the 
M-  state.  Immunochemical analysis of lysogenically converted  M + strains  demon- 
strated  that  they  contain  precipitating  and  antiphagocytic  determinants  of  the 
parental M-76 strain (CS110) rather than M-12 determinants expressed by the phage 
donor strain.  This information strongly suggests that the M- strain CS112 possesses 
the structural  gene for M  protein,  but  that  it  remains predominantly unexpressed. 
Quantitation  of the  M  antigen  produced  by these strains supports  the observation 
that the M- phage-recipient strain possesses a small amount of extractable M  antigen 
and that phage activates its synthesis by some unknown  mechanism. Various possi- 
bilities to account for the phage requirement in M  protein synthesis and its role in the 
transition between M + and M- states are discussed. 
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